Current Issue May 2012, Vol. 163, No. 5

Issue Highlights

Percutaneous left ventricular partitioning in patients with chronic heart failure and a prior anterior myocardial infarction: Results of the PercutAneous Ventricular RestorAtion in Chronic Heart failUre PaTiEnts Trial
May 2012 (Vol. 163 | No. 5 | Pages 812-820.e1)
Ernest L. Mazzaferri, Sinisa Gradinac, Dragan Sagic, Petar Otasevic, Ayesha K. Hasan, Thomas L. Goff, Horst Sievert, Nina Wunderlich, Serjan D. Nikolic, William T. Abraham
The SPIRIT V Diabetic Study: A randomized clinical evaluation of the XIENCE V everolimus-eluting stent vs the TAXUS Liberté paclitaxel-eluting stent in diabetic patients with de novo coronary artery lesions
May 2012 (Vol. 163 | No. 5 | Pages 867-875.e1)
Eberhard Grube, Bernard Chevalier, Giulio Guagliumi, Peter C. Smits, Marrianne Stuteville, Cécile Dorange, Peggy Papeleu, Upendra Kaul, Vladimír Džavík
Long-term clinical and angiographic outcomes of diabetic patients after revascularization with early generation drug-eluting stents
May 2012 (Vol. 163 | No. 5 | Pages 876-886.e2)
Michael Billinger, Lorenz Räber, Sarah Hitz, Giulio G. Stefanini, Thomas Pilgrim, Christoph Stettler, Thomas Zanchin, Cedric Pulver, Nico Pfäffli, Franz Eberli, Bernhard Meier, Bindu Kalesan, Peter Jüni, Stephan Windecker

A pilot randomized study of ranolazine for reduction of myocardial damage during elective percutaneous coronary intervention
23 May 2012
Francesco Pelliccia, Vincenzo Pasceri, Giuseppe Marazzi, Giuseppe Rosano, Cesare Greco, Carlo Gaudio
Background: Ranolazine is a new antianginal drug that reduces intracellular sodium and calcium accumulation during ischemia, thus potentially limiting myocardial ischemia. It remains unknown, however,...
Multi-marker strategy of natriuretic peptide with either conventional or high-sensitivity troponin-T for acute coronary syndrome diagnosis in emergency department patients with chest pain: From the “Rule Out Myocardial Infarction Using Computer Assisted Tomography” (ROMICAT) trial
23 May 2012
Quynh A. Truong, James Bayley, Udo Hoffmann, Fabian Bamberg, Christopher L. Schlett, John T. Nagurney, Wolfgang Koenig, James L. Januzzi
Background: Compared to troponin alone, a dual-marker strategy with natriuretic peptides may improve acute coronary syndrome (ACS) diagnosis with a single blood draw and provide physiologic informatio...
Economic evaluation of telephone self-management interventions for blood pressure control
23 May 2012
Virginia Wang, Valerie A. Smith, Hayden B. Bosworth, Eugene Z. Oddone, Maren K. Olsen, Felicia McCant, Benjamin J. Powers, Courtney Harold Van Houtven
Background: Half of patients with hypertension have poor blood pressure (BP) control. Recent models for treating hypertension have integrated disease monitoring and telephone-based interventions deliv...
Cardiogenic shock complicating acute coronary syndromes: Insights from the Global Registry of Acute Coronary Events
11 May 2012
Hamza H. Awad, Frederick A. Anderson, Joel M. Gore, Shaun G. Goodman, Robert J. Goldberg
Introduction: Despite advances in the management of patients with an acute coronary syndrome (ACS), cardiogenic shock (CS) remains the leading cause of death in these patients. The objective of this o...
B-type natriuretic peptide level and postdischarge thrombotic events in older patients hospitalized with heart failure: Insights from the Acute Decompensated Heart Failure National Registry
11 May 2012
Robb D. Kociol, Melissa A. Greiner, Bradley G. Hammill, Zubin J. Eapen, Gregg C. Fonarow, Winslow Klaskala, Roger M. Mills, Lesley H. Curtis, Adrian F. Hernandez
Background: Patients hospitalized with heart failure (HF) have elevated B-type natriuretic peptide (BNP) levels and increased risk for thromboembolic events. Associations between BNP level and thrombo...

View More Articles in Press...

Efficacy of exercise-based cardiac rehabilitation post–myocardial infarction: A systematic review and meta-analysis of randomized controlled trials
October 2011 (Vol. 162 | No. 4 | Pages 571-584.e2)
Patrick R. Lawler, Kristian B. Filion, Mark J. Eisenberg
Rationale and design of RE-LY: Randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran
May 2009 (Vol. 157 | No. 5 | Pages 805-810.e2)
Michael D. Ezekowitz, Stuart Connolly, Amit Parekh, Paul A. Reilly, Jeanne Varrone, Susan Wang, Jonas Oldgren, Ellison Themeles, Lars Wallentin, Salim Yusuf
Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
November 2010 (Vol. 160 | No. 5 | Pages 785-794.e10)
SHARP Collaborative Group
Rationale and design of the Anti-Xa Therapy to Lower cardiovascular events in Addition to standard therapy in Subjects with Acute Coronary Syndrome–Thrombolysis in Myocardial Infarction 51 (ATLAS-ACS 2 TIMI 51) trial: A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome
May 2011 (Vol. 161 | No. 5 | Pages 815-821.e6)
C. Michael Gibson, Jessica L. Mega, Paul Burton, Shinya Goto, Freek Verheugt, Christoph Bode, Alexei Plotnikov, Xiang Sun, Nancy Cook-Bruns, Eugene Braunwald
Newest-generation drug-eluting and bare-metal stents combined with prasugrel-based antiplatelet therapy in large coronary arteries: The BAsel Stent Kosten Effektivitäts Trial PROspective Validation Examination part II (BASKET-PROVE II) trial design
February 2012 (Vol. 163 | No. 2 | Pages 136-141.e1)
Raban Jeger, Matthias Pfisterer, Hannes Alber, Franz Eberli, Søren Galatius, Christoph Naber, Giovanni Pedrazzini, Hans Rickli, Jan Skov Jensen, André Vuilliomenet, Nicole Gilgen, Christoph Kaiser

Most Read lists are compiled every quarter.

On the Cover

New Issue Alert

Free Trial Issue

About American Heart Journal

American Heart Journal has been a trusted resource for cardiologists and general practice physicians for more than 80 years. The Journal focuses its content to respond to the information needs of the cardiology community. In addition to publishing results of important clinical investigations, the Journal addresses such topics as cost-effectiveness, design of clinical trials, reports of negative clinical trials, and the changing organization of medical care.

Impact Factor

2010 Impact Factor* 5.052!
13 out of 114 journals listed
*Journal Citation Reports®, published by Thomson Reuters

Journal Access

Full-text articles and abstracts are available to personal subscribers starting from 1997 to the present; access to abstracts is complimentary. Click here for additional information.

Already have a username and password? Click here to log in.

First-time User? Create an account here.

Institutional subscribers: Click here to access your journal subscription.

Subscribe to the journal now!

Videos

Dr. Joseph Rogers (Full Size)

Video Collection Page

Dr. Matt Roe (Full Size)

Video Collection Page

Dr. Seth Glickman (Full Size)

Video Collection Page

Dr. Manesh Patel (Full Size)

Video Collection Page

Dr. Matt Roe (Full Size)

Video Collection Page

The First Call With Dad (Full Size)

Video Collection Page

Dr. Toby Weingarten provide methods in which emergency response teams can assess rapidly deteriorating patient conditions that may indicate earlier intervention options. Click here to learn more.

Video--flashvideo6jmcp--http://podcasts.elsevierhealth.com/jmcp/weingarten.flv--/webfiles/images/journals/jmcp/weingarten.png

Dr. Jennifer St. bryson provides information that will assist patients and clinicians in interpreting variations in PSA levels over time. Click here to learn more.

Video--flashvideo2jmcp--http://podcasts.elsevierhealth.com/jmcp/stbryson.flv--/webfiles/images/journals/jmcp/stbryson.png

shire Efforts in Communication

Transradial Angiography and Intervention Focus Issue: Call for Papers

In recognition of the increasing interest and adoption of transradial angiography and intervention, the American Heart Journal will publish a special section dedicated to transradial invasive procedures, in the September 2012 issue. Studies that will be considered for publication include observational analyses or randomized trials that examine technical issues, implementation, or outcomes. Manuscripts should be submitted by June 30, 2012.

To submit your manuscript and for Instructions to Authors, visit http://ees.elsevier.com/ahj/.

For further information, contact Guest Editor Sunil Rao, MD, at sunil.rao@dm.duke.edu.

Access this journal onSciVerse ScienceDirect

Publishing Information

American Heart Journal is published by Elsevier.